Exozymes Inc. · NASDAQ:EXOZ

Perriman Damien Alan exercised options for 19,612 Exozymes Inc. shares (Form 4)

Traded Aug 19, 2026 · Filed Aug 25, 2026

On Aug 19, 2026, Perriman Damien Alan (Chief Commercial Officer) exercised options for 19,612 Exozymes Inc. shares, leaving 28,499 shares. Filed Aug 25, 2026 (Form 4).

Options exercised
19,612 shares
Holding after
28,499 shares
Trading plan
No
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 19, 2026Common StockOption exercise19,61228,499Direct

Source

View original at SEC

Related